Home > Financial Ratios > MANGALAM DRUGS AND ORGANICS

MANGALAM DRUGS AND ORGANICS
EV/Core EBITDA

    Back to All Ratios
MANGALAM DRUGS AND ORGANICS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MANGALAM DRUGS AND ORGANICS
Please provide your vote to see the results

MANGALAM DRUGS AND ORGANICS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EV/Core EBITDA(x) 8.744.883.803.8814.88

What is the latest EV/Core EBITDA ratio of MANGALAM DRUGS AND ORGANICS ?

The latest EV/Core EBITDA ratio of MANGALAM DRUGS AND ORGANICS is 8.74 based on Mar2023 Standalone results.
Year EV/Core EBITDA
Mar20238.74
Mar20224.88
Mar20213.80
Mar20203.88
Mar201914.88

How is EV/Core EBITDA of MANGALAM DRUGS AND ORGANICS Trending?

Years EV/Core EBITDA % Change
Mar2023 8.74
79.10
Mar2022 4.88
28.42
Mar2021 3.8
-2.06
Mar2020 3.88
-73.92
Mar2019 14.88 -

Other Financial Ratios of MANGALAM DRUGS AND ORGANICS


Compare EV/Core EBITDA ratio of peers of MANGALAM DRUGS AND ORGANICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANGALAM DRUGS AND ORGANICS ₹161.6 Cr 0% 8.9% -13.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹364,315.0 Cr 1.1% -6.6% 56.7% Stock Analytics
CIPLA ₹114,614.0 Cr 0.2% -4.4% 54.3% Stock Analytics
DIVIS LABORATORIES ₹105,233.0 Cr 4.8% 18.9% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,900.0 Cr 4.3% 2.6% 29.9% Stock Analytics
ZYDUS LIFESCIENCES ₹99,426.0 Cr 2.2% -4.6% 86.6% Stock Analytics


MANGALAM DRUGS AND ORGANICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANGALAM DRUGS AND ORGANICS

0%

8.9%

-13.2%

SENSEX

1%

2.2%

23.7%


You may also like the below Video Courses